版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
中美仿制藥研發(fā)和申報流程涂家生,Ph.D.中國藥科大學藥劑學教授Tel:025-832713052011.11鄭州我國仿制藥申報、審評和研發(fā)對策主要內(nèi)容中美關(guān)于原研藥和仿制藥的背景美國仿制藥:申報、基于問題的審評和研發(fā)對策展望1234藥物經(jīng)濟學催生美國仿制藥制度美國社會安全制度導致政府赤字嚴重SSA已經(jīng)破產(chǎn):如何破局?降低醫(yī)療費用成為必然Hatch-Waxman法案出臺美國FDA藥品注冊申請:新藥(兩類)、仿制藥和非處方藥申請1984年后NewDrugApplications(NDAs)AbbreviatedNewDrugApplications(ANDAs)
“FullReports”ofSafetyandEfficacyInvestigationsApplicanthasrightofreferencetoessentialinvestigations?
DuplicateofanalreadyapprovedproductNosafety/efficacydatapermitted(onlybioequivalence)YESNO505(b)(1)505(b)(2)505(j)NDA的研發(fā)和申報505(b)(1)新藥申報資料內(nèi)容IndexSummaryChemistry,ManufacturingandControlSamples,MethodsValidationPackageandLabelingNonclinicalPharmacologyandToxicology6.
HumanPharmacokineticsandBioavailability7.Microbiology(foranti-microbialdrugsonly)8.ClinicalData9.SafetyUpdatereport(typicallysubmitted120daysaftertheNDA’ssubmission)10.Statistical11.CaseReportTabulations12.CaseReportForms13.PatentInformation14.PatentCertification505(b)(2):歷史過程HatchWaxman法案:1984ParkmanLetterPhantomANDAFDADraftGuidanceforIndustry(1999)FDAResponsetoCitizen’sPetition(2003)可以降低研發(fā)的費用和審評力量的浪費505(b)(2)的關(guān)鍵:可靠性Whatis“Reliance”Bywhom?Onwhat?RelianceandExclusivityMarketvs.DataExclusivitySafety/EfficacyDatavs.CM&CdataFDAProcessforDeterminingRelianceWho,whenandhow?505(b)(2)的意義介于全創(chuàng)新藥物和仿制藥之間具有專利保護,且不存在產(chǎn)權(quán)糾紛和仿制藥不同,無替換的要求
應(yīng)有突破505(b)(2)范圍NewChemicalEntity(rarely):我國Newdosageform:我國5類Newdosingregimen:我國補充申請Newstrength:我國補充申請Newrouteofadministration:我國2類Newindication:我國1.6505(b)(2)情形Newactiveingredient(differentsalt,ester,complex,chelate,clathrate,racemate,orenantiomerofactivemoiety)NewinactiveingredientthatrequiresmorethanlimitedconfirmatorystudiesRxOTCswitchNewCombinationProducts“Genericbiologics”505(b)(2)排他性Exclusivitiesavailablefor505(b)(2)productsNCEExclusivity(5years)NewProductExclusivity(3years)OrphanDrugExclusivity(7years)Pediatricexclusivityextensions(6months)PatentIssues505(b)(2)drugscanhaveOrangeBook-listedpatents,andenjoy30-monthstayprotectionagainstgenericcompetitorsBut,505(b)(2)NDAsmayalsobeblockedbypatentsonReferenceDrugs505(b)(2)新藥的成功例子NCEThalomid?(thalidomide)(1998)MarketedunapproveddrugsLevothyroxine(2000)Guaifenesinextendedrelease(2002)Quininesulfate(2005)NewDosageFormTramadolorallydisintegratingtablets(2005)Ondansetronoralspray(filed2006)505(b)(2)新藥的例子NewDosingRegimenTramadolextendedreleasetablets(2005)NewStrength/FormulationAntara(micronizedfenofibratecaps)(2004)(130mgisBEtoTricor200mg)NewFormulation/InactiveIngredientAvita(tretinoingel)(newemollient)(1998)Abraxane(cremaphor-freepaclitaxel)(2005)Oxy-ADF(oxycodoneformulatedtoreducedrugabuse)(indevelopment)505(b)(2)新藥的例子NewActiveIngredientPexeva(paroxetinemesylate)(newsalt)(2003)NewRouteofAdministrationEmezine(prochlorperazine)(newbuccal/transmucosaldelivery)(NDApending)Oralamphotericin-B(pre-clinical)RxOTCSwitchAlavert(loratadine)(2002)505(b)(2)新藥的例子“GenericBiologics”O(jiān)mnitrope(rHGH)(2006)Glucagen(glucagonrecombinant)(1998)Hyaluronidase(variousapprovals2004-05)Fortical(calcitoninsalmonrecombinant)(2005)*ExamplesbasedonpubliclyavailableinformationFDANDA審評過程FDA可以使用已有數(shù)據(jù)用于審評NDA嗎?Hatch-Waxman之前,國會限制FDA在審評NDAX時應(yīng)用NDAY的數(shù)據(jù):“NodatainanNDAcanbeutilizedtosupportanotherNDAwithoutexpresspermissionoftheoriginalNDAholder.”[FDA“FinkelMemorandum”(1978,1981)]Hatch-Waxman解除只適合ANDAs:ANDAprocessallows“genericproducerofthefullytesteddrugtorelyonthesafetyandefficacydataofapriorapplicant....”505(b)(2)doesnotauthorizesuchdatarelianceMerelysetsconditionsforcertainNDAsRequires“fullreportsofinvestigations”establishingsafetyandeffectiveness[21USC§§355(b)(1)(A),(d)(1)]美國仿制粘藥Ag繞ene遙ric返dr果ug列pro田duc油ti關(guān)so靜ne磨tha期ti餅sc戶omp丙ara道ble耍to娃an零in熟nov薦ato嫩rd具rug茫pr蝕odu敢ct各(a抓lso妖kn需own撲as加th獻er蒸efe腰ren景ce稠lis爛ted掛dr魯ug賞(RL辱D)般pro裳duc損ta跟si盆den圣tif歉ied姨in色th榴eF刊DA’險sl奏ist僻ofAppr羞oved烤Dru右gPr灣oduc桌tsw掩ith墊Ther疊apeu典tic盆Equi逆vale包nce瞧Eval沖uati播ons)in獎dos牽age改form互,st顛reng蜻th,巧rout索eof暑adm妙inis爹trat深ion,題qua扛lity敏,pe摟rfor默manc壺ech排arac噴teri引stic肆san越din運tend嫂edu彩se.Gen撲eri翼cd趴rug賀ap下pli優(yōu)cat壇ion國sa倘re攏ter牙m(xù)ed虜“a燃bbr豬evi扒ate的d”壞in紀tha萌tt獎hey慰ar埋eg坐ene信ral緊ly珍not要re烏qui悠red鋸to出in刻clu制de竭pre泳cli損nic別al趁(an泊ima拿l)梢and俊cl圣ini賤cal酸(h采uma探n)衣dat朵at貿(mào)oe蘋sta風bli擔sh爛saf防ety橫an劍de架ffe各cti抹ven磨ess長.The岡se英par杯ame友ter按sw庫ere牽es桃tab旬lis卷hed缸up插on濾the塌ap虹pro暫val語of衛(wèi)th鏟ei憂nno岸vat瓦or觀dru敬gp選rod范uct疾,w券hic位hi方st牙he艙fir上st及ver牢sio飾no溜ft驚he翼dru仇gp見rod容uct脅ap綠pro抱ved艘by若th巡壽eF最DA.FDA審評仿碌制藥程譜序二、美國秒仿制藥的浪申報、審猴評和研發(fā)豎對策由FDA的OGD審評審評方式攝采用QbR申報資料沿采用CTD資料內(nèi)容倡也針對問盛題Off毯ice顫of云Ge返ner腿ic屑Dru扯gs如何保五證審評缸質(zhì)量和秩效率?Stru夢ctur干edP素rodu雷ctL掌abel聾ing擾(SPL束)Make相sla昂beli降nga羽vail松able牛on撥Inte從rnet尖via搭Nat退iona幸lLi欄brar耐yof罵Med捉icin廟e(N亡LM)Rev壘iew醫(yī)Ef臂fic鴨ien劍cie督sEar梅ly耍DMF欺re佛vie摘wClus傷ter鳥revi茅ews濾–pr碑oduc呼tsp敞ecia擇list扭sSup脂ple臘men自tt菌ria陳gin蚊ga牽tt詞eam卷le在ade震rl刷eve揮lDBE教Trun嫂cate在dRe懲viewQue塵sti隊on術(shù)bas甚ed幕Rev墊iew未(Q仆bR)Wil吊lh逼ave拆a著ver通yp閉osi鬼tiv優(yōu)ei累mpa野ctNew予re愿sou蛋rce狂sd委eve媽lop浮edDis削sol永uti綢on擺Dat笨aba產(chǎn)seIndi棉vidu雕alP咐rodu濫ctB棕ioeq吐uiva除lenc黃eIn娃form情atio姨nEnc棉our費age娛dt番he張use宋of良te主lep男hon俯ei竿nr搶evi村ew雕pro附ces片sIncr臺ease弄dth抬enu舍mber獲of墾1stcycl門eap伯prov朗alsDecr抗ease廣dth岡eto我tal佳numb畫ero楊fre舊view嘴cyc沒lesTota視lti戶met漫oap尤prov假ald冬idn怪oti惠ncre漢ase廈ins恥pite箏of星incr南ease盯dwo譯rklo折adDissolutionMethodsforDrugProductsNew!!benThis劑gui袋danc梁eco寺ntai炒nsa富nInt浩ern處et興lin供kto符al施ist鎮(zhèn)ing犯of朵dr對ug茫pro拘duc痕ts,ea很chl妨inke巾din雄tur管nto炮ac搬orre劈燕spon視ding壇bio聚equi趨vale厚nce鍵reco蹦mmen粉dati勁on.作Cli竄ckin屑gon讓ap樂rodu帳ctn笛ame往int應(yīng)hat紅list血wil慢lbr腿ing超upt辭hebio館equ回iva施len痛ce肚rec教omm乏end最ati尿ons蜻fo輛rt住hat啞sp終eci雄fic侍pr滴odu透ct.Reco各mmen遷dati鴨ons軌have忌bee捷nde案velo球ped扮for峰seve攏ral停drug撒sth賀ata壺ren屋oty貪ete前l(fā)igi哥ble開for物gene耽ric械comp賄etit辯ion表(i.e榴.,n鼓ewly呈app蹈rove怖dpr太oduc述ts)干and拜some緩old蠅erp憶rodu較cts象for間whic頁hin鐮form菊atio碗nha納spr樸evio鬧usly顯bee柄npr區(qū)ovid慘ed.淡Asadd童iti桃ona犬lr粱eco糕mme彩nda浮tio汪ns魚are個de需vel椅ope謀d,汽tho極se迷wil革lb攔ep漢ost拜ed寧on茶the犬We川bs帝ite.W鍋hen湖this頌gui露danc娛eis奧fin撕aliz順ed,械the緞list錦ing歸will逼be蝦avai刻labl慈eth薦roug煙hth灶eAg客ency鉗’sW逮ebp慶age.OFFICEOFGENERICDRUGSTABLEOFBIOEQUIVALENCERECOMMENDATIONSActiveIngredientPotencyDosageFormRouteofAdministrationDateFinalizedAlmotriptanMalate12.5mgTabletOral5/16/2005Alosetron1mgTabletOral5/31/2005Atazanavir200mgCapsuleOral3/18/2005Atomoxetine60mgCapsuleOral6/13/2005CefditorenPivoxil200mgTabletOral3/18/2005Dutasteride0.5mgCapsuleOral7/5/2005Eplerenone50mgTabletOral3/18/2005FosamprenavirCalcium700mgTabletOral3/18/2005Memantine10mgTabletOral7/8/2005Rosuvastatin40mgTabletOral3/18/2005Tadalafil20mgTabletOral3/18/2005VardenafilHCl20mgTabletOral4/11/2005QbR:從提出到遭完善1/2爛005趕–費2/2炸005解:Que查sti逢on-肆bas屋ed如Rev雖iewDra置fte項d3/2而005停–難4/2借005什:D揀ivi邀sio看nD鴿ire疑cto弄rs睜Dis脆cus直sio鍋n5/2概005偷–嶺6/2徹005諒:T比eam次Le朗ade史rs暗Dis揪cus筒sio劣n7/20響05–構(gòu)8/2想005:爺Rev乎iewe丘rsD皂iscu鄭ssio骨n9/2嚴005兆–糞1/2貧006毀:M莖ode耕lP騾har克mac歡eut露ica層lD頭eve摘lop匙men跪tR花epo來rt鋸and悔Qu轟ali連ty珍Ove蛙ral祖lS托umm傭ary2/2俗005俯–童12/才200構(gòu)5:耍Dis皂cus摧sio竄ns感wit襪hS闊tak嚷eho率lde伴rs闊and奔Up溜per劈燕Ma渾nag皺eme應(yīng)nt1/20水05–簽12/隨2006痕:Gr寫adua撲l I隨mple胳ment塘atio筋n1/20身07:敢Full垃Imp沃leme幅ntat齒ionQbR的內(nèi)涵Ques普tion柜-bas澆edR卸evie蒸wis始ag畝ener偵alf賺rame達work稅for含as老cien閥cea禿ndr粒isk-股base叢das理sess涂ment叔of上prod謠uct奧qual匙ityQue氏sti廳on-球bas儀ed溉Rev烏iew儲co巨nta立ins蒼th當ei旗mpo廢rta映nt克sci雙ent診ifi禿ca翁nd濕reg拐ula慎tor倚yr難evi塔ew千que陡sti廉ons要to關(guān)鍵制備裝工藝及其扎質(zhì)控產(chǎn)品的績工藝、塞處方是仗否有設(shè)酸計缺陷強調(diào)QbDANDA與sUn努derQbR(Con嫌tinu治ed)Fut附ure輛Ge決ner下ic飯App得lic膛ati帳onsgene笛ric好spon煎sors捷sub瞞mit蘋gene卸ric積appl昆icat間ionsbase舅don分the扯for左mat岡ofI庸CHC唱TD,葬pref消erab偏ly,烈elec豈tron急ical崗lyMod水ule程1:俊Ad魚min侍ist模rat腥ive尋In文for報mat伏ionMod辨ule抖2:款Qu弱ali叨ty昌Ove煉ral猾lS栗umm誓ary閃an優(yōu)dC董lin認ica靠lS罪umm豎aryMod錦ule暮3:燭Qu憐ali臉tyPha莫rma素ceu種tic閘al肯Dev窯elo進pme茶nt;申Qu免ali告ty繩by娘Des奸ignModu廟le4援:No怠ncli豈nica殊lModu夏le5穩(wěn):Cl肉inic壯al(延Bioe石quiv搬alen罷ce)新藥申報圣(NDA)和仿制藥托申報(ANDA)的比服較1.Chemistry2.Manufacturing3.Controls4.Labeling5.Testing6.AnimalStudies7.ClinicalStudies8.BioavailabilityNDA號requ喬irem鋤entsAND戴Ar揪equ憂ire躲men隱ts1.Chemistry2.Manufacturing3.Controls4.Labeling5.Testing6.Bioequivalence美國仿涌制藥申哨報模塊1包含了管理和處方信息,這個是區(qū)域特異的。在美國應(yīng)包括以下信息:①申請書3674;②專利認證信息;③原研藥信息,包括NDA號、藥名和生產(chǎn)商;④仿制藥和原研藥的對比,包括使用條件、有效成分、非有效成分、給藥途徑、劑型和劑量;⑤環(huán)境影響分析;⑥藥品說明書(草稿)。
模塊2模塊2為概論。它包括藥理作用分類,作用模式以及臨床適應(yīng)證。模塊3應(yīng)該包含原料藥和制劑相關(guān)的化學、生產(chǎn)和質(zhì)量控制信息。FDA仿制藥部宗(OGD)鼓勵誓申請人壇根據(jù)ICH對于人用即藥物的注象冊技術(shù)要壩求,即通肝用技術(shù)文堂件(CTD)的格監(jiān)式,提絡(luò)交ADNA。包括劃以下模飼塊:模塊4模塊4是關(guān)于動物實驗的信息,并不是ANDA要求的。所以,仿制藥申請一般不包含模塊4。
模塊5模塊5是臨床研究報告。對于ADNA,生物等效性信息應(yīng)該在這個部分體現(xiàn),包括:①生物等效性研究;②體外-體內(nèi)相關(guān)性研究;③生物分析方法開發(fā)。案例報告,包括不良反應(yīng)事件報告也應(yīng)包括在此。
OGD蟲QB畫RThe錄ques逮tion熔bas帥edr撈evie斬w(Q型BR)叛serv遵esa襖sagene倉ralfram修ewor半kfo籠rth館eCM辭Cas斜sess僚ment富of票ANDA快sth尖atf湖ocus枯eso樸ncr仍itic息alp在harm灰aceu提t(yī)ica庸lat袍trib舅utes鮮of療prod顆uct哈qual聰ity.送Wi斜thj妖usti魚fica如tion短,de譜viat毀ions爐or勵alte爬rnat獻eap撒proa朵ches鍵to攜this拳fra蝦mewo賓rkc毀anb輝eut旅iliz飄e,a挨sne鍛cess投ary,故to蹦ensu涼ret棟hea殲dequ本acy嚷oft鮮hea灶sses傻smen考tof凱pro顆duct舍qua砌lityFor晝ea唯se茫of慌dis貴cus箏sio臨n,諸as丈imp板le釀dos瘋age漂fo每rm呢is懷def園ine伸da淺sa磨so販lut引ion棉or屢an謎im抽med抗iat枯er們ele見ase算(I宿R)見sol斥id輕ora蟻ld薦osa寫ge伶for宿m.QBR:Drug胞Sub腿stan危ceDes出cri帥pti畢on密and綠Ch銅ara棟cte泊riz曾ati穿onWha癥ta彩re杏the沾no碑men甲cla鄉(xiāng)豐tur芝e,泰mol執(zhí)ecu舊lar彩st峰ruc秀tur炎e,言mol鈔ecu妙lar羅fo省rmu答la,議an耍dm腐ole探cul紹ar綢wei宗ght稅?Wha芽ta糖re雀the霧pK吼a,隊aqu咽eou扒ss繪olu蠶bil凱ity擠(a哭sf鑼unc峽tio村no牌fp問H),睜pa瘦rti漁tio壘nc堅oef些fic聲ien析t,擱pol綢ymo完rph溜ism抓,h龍ygr副osc聲opi錘cit統(tǒng)y,展and兵me紫lti驅(qū)ng材poi徒nts毒?Con翻tro掠lo嘗fD爹rug意Su偽bst唐anc超eApp貢ear掛anc嚼ea兼nd眼Ide戴nti碧fic吃ati缺onAre毫th庸es尋pec謙ifi朽cat他ion喝sf期or裁app歪ear眨anc蠅ea輸nd商ide腰nti雀fic揀ati急on預app貧rop保ria肯te?Ass歐ayIs姑the宵pr雙opo盲sed娛dr鬼ug組sub灘sta很nce沸as窮say債li罰mit耐ac仇cep秀tab孕l(wèi)e?Is象the注an脆aly廈tic賺al渡met搖hod赤va肅lid圣ate港da涉nd滾sta濱bil謝ity徒-in病dic鹿ati卻ng?Imp強uri懲tie撐sa末nd蟲Res吉idu脾al眠Sol弄ven冊tsAre計al閑lt筋he喇pos盟sib洗le黑imp扔uri伸tie河sa林cco落unt側(cè)ed莖for拜?What摟is植the主just架ific牲atio斬nfo居rth攀eim同puri炭tya家ccep條tanc仙eli箱mits鐵?Are圈th腥ea就nal火yti蠅cal已me與tho災ds醋val赴ida辮ted枝an罪ds餓uit黎abl哥ef肚or禿the捏ir柴int咱end闊ed悔fun頑cti乓on?Add較iti任ona籮lS頭pec駱ifi杯cat炸ion支sBas跨ed叉on規(guī)the巧re羅vie惜wo村ft煤he月dru崖gp面rod降uct木an溪dm仍anu省fac元tur解ing名pr晶oce繼ss節(jié)are王sp毒eci美fic構(gòu)ati葡on(紹s)噴req贊uir嫌ed耕on擠par匆tic叛le邁siz怎e,恭sol報id怒sta印te克for贊m,猛moi控stu瓶re乞con饒ten宴t,眾or根oth臨er域pro顛per芽tie漠so沒ft脆he該dru具gs麗ubs趕tan猜ce歪and吳wh棒y?For擇each伶add轎itio蘿nal化spec予ific茅atio壤n:W野hat匪ist套hej割usti幣fica麻tion全for坐the譽acc作epta猶nce漸limi棕t?I階sit繁sui咐tabl枯efo錘rit港sin猾tend劫edf康unct億ion?QBR:Drug驢Pro拆ductDesc稈ript根ion嘩and燙Comp鉆osit熱ionWhat證are案the向com喉pone奪nts盆and絨comp哄osit參ion呈oft周hef石inal停pro侄duct掘?Wh救ati率sth湖efu輪ncti宣ono苦fea幫che末xcip沈ient釀?Doa汽nye幼xcip嘴ient菌sex議ceed潑IIG啄lim餃its聲int證hec非onte彎xto拍fma生ximu鹽mda船ily倉dose鴿and旗rou港teo筒fad拒mini博stra漂tion淺?If普pro跳duc省ti范sa零nN稅TI竄dru沒go偵ra攝no生n-s侄imp獄le私dos營age釘fo籠rmAre負th幟ere陪si俱gni雄fic寨ant眠di雕ffe滴ren晶ces妻be迷twe萄en仗thi董sf匠orm擾ula叨tio炸na湊nd腰the睬RL父Dt賽hat強pr傷ese籍nt殊pot質(zhì)ent父ial鈴co盒nce繳rns僻wi嗚th撒res校pec翼tt逮op填rod持uct爸pe結(jié)rfo指rma諷nce魂?Con議tro宰lo始fE唯xci錯pie昏ntsWha忽ta印re徐the歪sp值eci奧fic綁ati津ons選fo檔rt瘦he唇ina蹲cti撫ve耍ing嚷red淋ien折ts雀and多ar忙et永hey曠ap微pro拼pri采ate垮pe愿rt膛hei仇ri野nte翁nde潔df覽unc隙tio使n?Simp蔥leD碗osag叛eFo司rm:碎Eith漂era鞠sol羊utio兼nor連an朝IRs朗olid看ora拾l(fā)do疼sage投for猜mQBR:Drug鉆Pro呈duct技(Co虧ntin蛛ued)Manu喜fact信ureFor偏al蕩lp暗rod始uct壇sDoe爺st駱he磁bat外ch誤for顧mul該aa抱ccu賄rat嗽ely紙re虛fle鞏ct厲the烘dr申ug常pro爹duc揚tc差omp丘osi障tio炊n?長If卷no我t,雷wha硬ta伍re凍the禁di粉ffe贊ren軌ces遇an于dt陜he健jus切tif噸ica敲tio初ns眠(e.珠g.耗pot街enc謙ya耳dju襯stm野ent植,o就ver靠age婦,e安xce載ss耀coa明tin狀gs雪olu點tio土n,借etc番.)?If誕pro跑duc第ti教sn攝ot種as析olu洞tio忽nWha成ta掃re舅the咸ke靠yu河nit免op鴨era蛋tio湯ns水in截the爆dr艙ug攝pro爸duc疼tm旅anu系fac廣tur事ing禍pr抓oce統(tǒng)ss?Are咳in委-pr佩oce紅ss匯tes明ts淋ide捏nti怎fie呀db鐘yt碎he唯spo艱nso般ra嗚ppr燭opr療iat忘e?Wha差ti鍵st深he且dif棉fer伐enc養(yǎng)ei等ns爬ize究be逃twe卡en駛com屢mer選cia枯ls木cal捎ea桃nd公bio預bat感ch盡and岸do衰th嚷ey董use蛋th那es釘ame唯un表it浪ope謠rat蘆ion滅s?Ifp磨rodu噸cti老san壁NTI櫻dru懶g(shù)or脂an體on-s茫impl勸edo煎sage土for激mWha攤ta沸re裁the露cr印iti跪cal窗st峽eps吸in監(jiān)th瞎em辦anu孫fac潤tur啊ing火pr期oce豎ss?What捆are保the強in-讓proc驗ess待test酬s/co崇ntro竹lst躺hat冠ensu岡ree透ach轟crit鳴ical耗ste袍pis者suc破cess及ful?Int切hep驚ropo肆sed鵲scal蠶eup擁pro虛cess種wha柿top羽erat雙ing淘cond珠itio滅nsw算ill濤bea巾djus團ted曾toe低nsur烏eth挽epr性oduc燦tme秧ets魔all套in-p京roce漏ssa下ndf擦inal修pro嗽duct工spe奮cifi比cati泰ons?Why勇doy聯(lián)oub按elie榜vet好hes虜pons抓orh箭asd弊emon銳stra率ted聞are般ason場able近pla轉(zhuǎn)nto早sca竟leu惕pth只epr凝oces框s?QBR疾:Drug盼Pro揮duct垮(Co伯ntin殘ued)Cont見rol頃ofD灶rug膜Prod泉uctIde抱nti慢tyIs教the訂sp典eci富fic陶ati桶on卸for梁th黑ei瀉den紹tit顛yo仇ft騎he念dru溜gp徒rod去uct江ap負pro若pri君ate柿?Assa沸yan跡dUn并ifor育mityAre魔the慕prop確osed站dru鑒gas頂say嚷limi民tsa綿ccep喇tabl糾e?Ist撥hea尾ssay示met搖hod閘vali鐵date筆dan這dst鄭abil狂ity-激indi唐cati緞ng?How緩is桌th恢ec科ont碌ent赴un風ifo璃rmi面ty跑eva銹lua豬ted恭?I混si沫ta訴cce僚pta縱ble免?Impu懂riti摟es/D討egra矛dati位onP贈rodu協(xié)ctsAre落th刷ed叫egr污ada授tio財np巾rod欺uct濁sa覺nd柔t(yī)he瓜ir管ori圖gin俗sa植deq速uat嘉ely戰(zhàn)de縱scr娘ibe捎d?Wha淺ti群st惕he底jus趴tif丘ica軌tio灑nf虎or閑the各ac岡cep呈tan使ce般lim硬its華on借de愧gra蒼dat遵ion織pr妖odu旋cts紹?Are趁th轉(zhuǎn)ea漸nal捐yti購cal害me絹tho烏ds行val友ida腿ted凝an外ds喚uit床abl爪ef速or崗the衣ir既int模end余ed言fun謙cti胡on?Diss機olut滑ionWha畏ta挺re搏the填di拘sso燙lut降ion蔥me諷tho艇ds堂and岡ac輛cep把tan卻ce茫cri當ter斜ia悲and柔ho痰ww鳥ere央th禁ey孔sel贊ect忍ed?Wha瘦ti負st揪he梢sig則nif顏ica大nt殿rol劑eo舍fd普iss扎olu剪tio確nt俱est棚ing如fo播rt糾his勤pr年odu莫ct?Addi言tion產(chǎn)alS膝peci奇fica團tion挑sAre跟th君ere源ad愧dit責ion廟al踢spe藏cif貝ica帝tio嶺ns狡tha槽ta黎re柄req處uir阻ed充to撒ens而ure牧th伏ep忠rod潤uct巾wi濾ll自per居for櫻ma衡sl期abe包led伯a(chǎn)n豪dw減hy?For莖each煮add瓜itio香nal物spec爪ific截atio柴n:W德hat翻ist使hej蝦usti解fica鴨tion稻for躍the控acc鋪epta苗nce匯limi趣t?A姐ret多hea識naly紋tica航lme熄thod尼sva嘩lida皂ted裕and蠅suit冊able蜘for祥the濟iri林nten踐ded菠func慌tion抄?QBR謝:Drug緣瑞Pro解duct盟(Co腦ntin旬ued)Refe柳renc吊eSt窮anda決rdAre貪ther很ea衣qual納ific清atio坦nre流port犬a(chǎn)nd孟COA啟pro繞vide浴dfo善rth戚ere貿(mào)fere鋸nce濟stan篩dard駱or判ist鎖his杰mate映rial究pur連chas父edf裹rom害ana趁ppro出pria篩tes隙ourc賣e?Con擊tai賭ner敢/Cl院osu從re夜Sys受temHas旗the玩cont位aine距r/cl焦osur虛esy休stem尾bee者nus賢edi勿na丸prev算ious穗lya橡ppro投ved復prod志uct甘oro妹ther章wise緣瑞qua受lifi隸edf魔ort路his獸dosa銳gef銜orm?Wha對ts至pec可ifi逆cc廣ont滋ain糾er/順clo斑sur滲ea奸ttr地ibu愉tes庸ar助en齒ece削ssa概ry塞to萄ens芽ure糞pr誘odu債ct梅per叫for驚man聞ce?Drug擾Pro票duct押Sta染bili泳tyDat怨aWha漫ts繭tab萍ili剖ty幻玉dat歌ah擋as榨bee笛ns粘ubm勞itt傍ed?民H雜as詢the須sp組ons跟or屋pro寄vid蹈ed號sta懸bil擦ity潮da藍ta秘for猴th毒ed頑rug略pr蹲odu傻ct報pac債kag租ed費in撓the評pr垮opo請sed槐co棚nta爭ine招r/c側(cè)los秀ure碧?Acce駱ptan孤cel俗imit伸sAre曠al桂la仍ttr收ibu路tes貫th舅at圓cou靠ld足cha炎nge旁ov配er饞tim囑ee兆val莖uat釘ed葬in咸the師st同abi肯lit這yt流est答s?Wha似ta捧re明the衫ac臟cep職tab占le仁lim備its剃on歡th植ese振at寸tri涉but數(shù)es?Shel蒜f-li債fer罷ecom隸mend反atio軋nWha侄ti怒st桃he贊jus棉tif叮ica睬tio段no杏fs毛hel標fl恐ife稼?Ist與hep濁ost-溫appr福oval起sta頌bili巖typ賤roto廁col顏acce安ptab似le?QBR鞭:Pro掀duc優(yōu)tD壓eve耐lop盛men驚tR醬epo喝rt窄for傳Co秋mpl皇ex登Dos盡age促Fo愚r(nóng)ms扔an匠dN竹TI難Dru猴gsDrug稀Sub突stan釀ceWhi障ch滑pro奔per橫tie獲so脫rp誕hys隸ica合lc糖hem桌ica題lc尺har歌act想eri藏sti煤cs愁of敵the孩dr促ug心sub疫sta控nce社af虜fec林td拿rug餡pr查odu逮ct悲per掠for悠man纖ce?Exci隆pien殃tsIst浩here別any覆evi舟denc靠eof商inc硬ompa柴tibi亭lity浴bet嫩ween劑the啞exc森ipie堡nts歷and勒drug旱sub次stan監(jiān)ce?For另mul穴ati辣onWhat簽is釋the叮form鼓ulat喂ion雪inte賺nded患to賓do?What蒜mec道hani伏smd已oes儀itu晴set密oac利comp濃lish秋thi決s?Wer挖ea差ny呀oth妹er燭for言mul靜ati洞on里alt公ern命ati駝ves肆in攻ves啟tig搜ate奇da蜂nd潤how補di業(yè)dt尖hes苦ep將erf腳orm順?Wer盼ea撒ny綿for床mul弊ati萬on盲opt鏡imi局zat戰(zhàn)ion搞or裝se令nsi尾tiv廢ity對st征udi版es丙car添rie旺do壩ut伸for離va雪ria壘tio棕ns們in伙com激pos屈iti料on雷aro捏und鏈th膽ef僅ina恒lf潛orm卡ula糊tio價n?暫We心re來the過se定stu偷die杰ss歷uff穿ici耀ent釀to詳es升tab捧lis像ha姜de帆sig逃ns汪pac予ef撐or彈for是mul精ati泊on憶com俱pos胖iti夏on?Ist垃hef頑ormu偶lati蠟ond歪esig忍nco嬌nsis股tent蹲wit杜hth習edo渠sage芒for蹄mcl僻assi宏fica司tion辮in析the湖labe隱l?Dru需gP呼rod尸uctWha婆ta女re肺the導cr版iti根cal芽qu次ali清ty野att努rib繼ute動st巖hat薯en鞋sur疾et朋he艙pro踐duc笛tw題ill妹pe交rfo詞rm獎as溜lab羞ele蘿d?QBR:Pro尖ces務(wù)sD改eve已lop博men蓬tR糠epo僅rtProc誓ess警Desc儀ript殃ionWhy置was愿this勇man登ufac抵turi釘ngp麗roce強sss占elec簡ted殘for鏟this那dru切g(shù)pr省oduc冒t?Wer簡ea保lte套rna蘆tiv餅eu竹nit方op狐era貞tio貫ns椅inv幻玉est俊iga浩ted所by悼pr猛oce賊ss欲dev碎elo全pme躍nt鼠stu覽die各s?Crit恨ical疼Ste衫psa蝕ndS匹cale離UpHow熱we另re釋the包cr干iti仔cal聽st蹲eps妙in綱th款ep爸roc琴ess及id坊ent董ifi進ed?Wha暫ta砍re恥the驚cr佳iti歇cal零pr肌oce繡ss借par耀ame土ter乓sf聰or零eac疼hc腔rit梨ica播ls蘇tep善an性dh狼ow嚷wer際et年hey筋id怨ent耳ifi江ed,食mo普nit衡ore憐da姑nd/復or煌con扮tro鍋lle辭d?Were勁pro子cess聚dev矛elop暫ment掀stu曉dies暑tha驢tva傻ried禿sta貸rtin嫂gma此teri丘als肺oro旋pera蔬ting飛par手amet它ers咬cond泡ucte酬d?W寸ere序thes暗est肢udie撲ssu欺ffic闖ient歲to竿esta劇blis或ha宋desi尸gns浩pace恨for膨pro敬cess勁?In招pro責ces盤st熟est哭sWhy掉is照ea摸ch擁in田pro罩ces筐st稀est駝re給qui奧red去?How氣we茫re星the莊ac雄cep減tan卸ce屠lim鉗its泉ch翠ose群n?Why此we握re糠the杠in籍-pr是oce納ss謎tes痛ts圾ide晚nti杜fie搏da奶sc欄rit哄ica擾lt腿op蟻rod姻uct祝qu嫁ali孤ty?What蠅sca釣le-u賢pex框peri店ence運doe存sth范esp雞onso船rha戰(zhàn)vew魚ith利the興unit叢ope寺rati脂ons保int肝his錄proc抄ess?QBR向:Ris昆kS爪umm明aryNTI盜drugCla意ssi泛fie樣da脂sa脹no轎n-N伙TI砌dru朱g,著ris婚ks承cor種e=羽+丘0Clas午sifi鍋eda痕san陶NTI號dru倍g,r雞isk忽scor鎖e=相+1Dos堪age厚Fo肆rmSimp扔leD剖osag悅eFo瓣rm,管risk云sco袖re=系+0Oth辨er塘Dos筒age跡Fo翼rms嚇an窩dN抱TI資dru繼gs,洋ri苦sk且sco臨re次=+撥1Dev蒙elo丟pme廈nt設(shè)Rep霞ortIft待hes亦pons神ors極ubmi而tsa辭dev肢elop瞎ment膚rep邪ort倡that庸add江ress切est肉heF濁DA’s麗que今stio括ns:耕Risk員sco默re=儉+0Solu疼tion眨and支IR獲Prod梨ucts性:P河rodu膜ctD告evel武opme欲ntR己epor坐tOthe呆rDo對sage菊For席ms:第Pro賄duct乘and濤Pro哄cess認Dev盆elop星ment虎Rep衰ortsIns享uff恰ici在ent潤or柜mi太ssi拖ng街dev聾elo胡pme尖nt石rep鑄ort痕,r即isk市sc六ore朗=及+1Ift爬hea憤ppli遭cati樹oni撤sof語hig稿hov塵eral瞧lqu語alit謝yLess鎖tha規(guī)nor廈equ裹alt長o2璃cycl健es,抵risk貨sco飾re=針+0頂.Gre鴿ate希rt扇han刻2開cyc蝕les丑,r賽isk限sc徐ore多=日+1QBR:Ris纖k-B確ase緞dC菊onc羨lus耍ionShou賴ldt滿hea型ppli薪cati社onb肚eap綿prov淡ed?What創(chuàng)pos刮t-ap堡prov孫alw藥aive濟rs/c飯ommi黑tmen祖tsa猴rea矩ppro腫pria叉tef少ort建his互prod順uct?Ift隊het躲otal橋ris布ksc坑ore蜘isl鞭ess哨than肉or拒equa平lto聯(lián)1CBE0
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年洛陽市公安機關(guān)招聘輔警人員筆試真題
- 2026交通運輸部所屬事業(yè)單位第四批招聘160人備考題庫及答案詳解1套
- 2026年語言學概論及語言應(yīng)用技巧考試題庫
- 2026年財務(wù)分析中級筆試題目集資本市場分析
- 2026年法律知識考核合同違約金計算及年度結(jié)算規(guī)定題
- 2026年企業(yè)文化建設(shè)與管理理論考試題
- 2026年企業(yè)財務(wù)管理實操能力測試題
- 2026年人力資源管理實務(wù)考試題集
- 2026年人工智能與未來教育趨勢題庫
- 2026年教師資格筆試之班級管理與學生心理健康應(yīng)用題
- 氫能源汽車2026年維修培訓
- 南京南京市建鄴區(qū)2025年9月政府購崗人員招聘筆試歷年參考題庫附帶答案詳解
- 2025年企業(yè)內(nèi)部培訓課程體系
- 2026年工程材料企業(yè)物資采購人員考試大綱
- DB11∕T 689-2025 既有建筑抗震加固技術(shù)規(guī)程
- 2025年湖南公務(wù)員《行政職業(yè)能力測驗》試題及答案
- 2024中國類風濕關(guān)節(jié)炎診療指南課件
- 2026年中國家居行業(yè)發(fā)展展望及投資策略報告
- 2025年地鐵車站物業(yè)管理合同協(xié)議
- 2025-2030腦機接口神經(jīng)信號解碼芯片功耗降低技術(shù)路線圖報告
- 2025公路安全韌性提升技術(shù)指南
評論
0/150
提交評論